Eris Lifesciences need to focus on export market, invest in R&D activities for future growth

Eris Lifesciences (Eris), which entered capital market in June 2017, has recently acquired nutraceuticals maker UTH Healthcare Ltd in a fully cash deal for a consideration of Rs. 12.85 crore.

More From BioPortfolio on "Eris Lifesciences need to focus on export market, invest in R&D activities for future growth"